ProMetic Life Sciences Inc.

TSX: PLI

MONTREAL, QUEBEC--(Marketwire - Nov. 12, 2008) - ProMetic Life Sciences Inc. (TSX:PLI) ("ProMetic") announces that it will be hosting a conference call and webcast on Friday, November 14, 2008 at 09:00 (EST) following the release of its third quarter 2008 financial results on Thursday, November 13, 2008 after close of market.

The conference call may be accessed by way of telephone or webcast. The numbers to access the conference call are (416) 644-3428 (international) and 1 (800) 814-4862 (toll free). A live audio webcast of the conference call will be available through ProMetic's website at http://www.prometic.com/en/investors... . Please connect at least five minutes prior to the conference call to ensure adequate time for any software download that may be needed to hear the webcast. A replay of the call will be available by telephone for a period of seven days as of Friday, November 14, 2008 at 12:00 (EST). The numbers to access the audio replay are (416) 640-1917 (international) and 1 (877) 289-8525 (toll free) using access code 21289053. Afterwards, the webcast may be downloaded directly from ProMetic's website.

About ProMetic Life Sciences Inc.

ProMetic Life Sciences Inc. ("ProMetic") (www.prometic.com) is a biopharmaceutical company specialized in the research, development, manufacture and marketing of a variety of commercial applications derived from its proprietary Mimetic LigandTM technology. This technology is used in large-scale purification of biologics and the elimination of pathogens. ProMetic is also active in therapeutic drug development with the mission to bring to market effective, innovative, lower cost, less toxic products for the treatment of hematology and cancer. Its drug discovery platform is focused on replacing complex, expensive proteins with synthetic "drug-like" protein mimetics. Headquartered in Montreal (Canada), ProMetic has R&D facilities in the U.K., the U.S. and Canada, manufacturing facilities in the U.K. and business development activities in the US, Europe, Asia and in the Middle-East.